Gastroesophageal Reflux in Asymptomatic Patients with Diabetes: An Impedance Study Diabetes, Obesity and Gastroesophageal RefluxFunding: The purchase of the esophageal impedance-pH meter catheters used in the study was supported by Istanbul University Rectorate Scientific Research Projects (Project Number 16174).
received 03 September 2018
revised 17 October 2018
accepted 31 October 2018
20 November 2018 (online)
Introduction Gastroesophageal reflux disease (GERD) is more frequent in patients with diabetes mellitus (DM).The aim of the present study was to evaluate gastroesophageal reflux (GER) in asymptomatic patients with DM using 24-h pH impedance.
Materials and Methods 19 healthy controls and 35 patients with DM without typical GERD symptoms were enrolled in the study. A 24-h pH-impedance study, esophageal manometry and gastroscopy were performed on all patients with DM. In the control group, an impedance study was performed on all subjects, and gastroscopy and esophageal manometry were performed on those who consented to the procedures. Patients with diabetes were categorized as obese [body mass index (BMI)>30 kg/m2] or non-obese (BMI<30 kg/m2) and both groups were compared with healthy controls.
Results The mean BMI was similar in the control group (27.3±2.6 kg/m2) and the diabetic group (28.7±5 kg/m2) (p>0.05).Erosive esophagitis was found in 7.5% of the DM group. Esophageal dysmotility was higher in diabetics compared to the control group (45.5 vs. 11%, p=0.04). Neuropathy was found to be an independent risk factor for dysmotility. The mean DeMeester score (DMS) (25.6±32.5 vs. 11.2±17, p=0.01) and bolus exposure time (2.1±1.3 vs.1.3±1.3 min, p=0.009) were higher in the DM group compared with the control group.The difference was mainly observed between obese diabetics and the control group (p<0.05). The mean DMS, pathologic acid reflux, and esophageal dysmotility rate were higher in patients without complications of DM (p<0.05). BMI was higher in these patients than in patients with complications.
Conclusion Acid reflux is common in patients with diabetes.GER is associated with the existence of obesity rather than hyperglycemia.
- 1 Katz LA, Spiro HM. Gastrointestinal manifestations of diabetes. N Engl J Med 1966; 275: 1350-1361
- 2 Hirata A, Kishida K, Nakatsuji H. et al. High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome. Nutr Metab (Lond) 2012; 9: 4
- 3 Lauffer A, Forcelini CM, Ruas LO. et al. Gastroesophageal reflux disease is inversely related with glycemic control in morbidly obese patients. Obes Surg 2011; 21: 864-870
- 4 LLuch I, Ascaso JF, Mora F. et al. Gastroesophageal reflux in diabetes mellitus. Am J Gastroenterol 1999; 94: 919-924
- 5 Nishida T, Tsuji S, Tsujii M. et al. Gastroesophagealrefluxdisease related to diabetes: Analysis of 241 cases with type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19: 258-265
- 6 Akyuz F, Uyanıkoglu A, Ermis F. et al. Gastroesophageal reflux in asymptomatic obese subjects: An esophageal impedance-pH study. World J Gastroenterol 2015; 21: 3030-3034
- 7 Silny J. Intraluminal multiple electric impedance procedure for measurement of gastrointestinal motility. J Gastrointest Mot 1991; 3: 151-162
- 8 WHO. Obesity: Preventing and managing the global epidemic. Report on a WHO Consultation on Obesity, Geneva, 3–5 June, 1997. WHO/NUT/NCD/98.1. Technical Report Series Number 894. Geneva: World Health Organization; 2000
- 9 Zerbib F, Roman S, Bruley Des Varannes S. et al Normal values of pharyngeal and esophageal 24-hour pH impedance in individuals on and off therapy and interobserver reproducibility. Clin Gastroenterol Hepatol 2013; 11: 366-372
- 10 Lacy BE, Weiser K. Esophageal motility disorders: Medical therapy. J Clin Gastroenterol 2008; 42: 652-658
- 11 Mantyen T, Farkilla M, Kunonamo I. et al. The impact of upper GI endoscopy referral volum on the diagnosis of gastroesophageal reflux disease and its complications: A 1-year cross sectional study in a referral area with 260.000 inhibitants. Am J Gastroenterol 2002; 10: 2524-2529
- 12 Lee SD, Keum B, Chun HJ. et al. Gastroesophageal reflux disease in type II diabetes mellitus with or without peripheral neuropathy. J Neurogastroenterol Motil 2011; 17: 274-278
- 13 Krishnan B, Babu S, Walker J. et al. Gastrointestinal complications of diabetes mellitus. World J Diabetes 2013; 4: 51-63
- 14 Frokjaer JB, Andersen SD, Ejskjaer N. et al. Impaired contractility and remodeling of the upper gastrointestinal tract in diabetes mellitus type-1. World J Gastroenterol 2007; 13: 4881-4890
- 15 Yang J, Zhao J, Liao D. et al. Biomechanical properties of the layered oesophagus and its remodelling in experimental type-1 diabetes. J Biomech 2006; 39: 894-904
- 16 Gustafsson RJ, Littorin B, Berntorp K. et al. Esophageal dysmotility is more common than gastroparesis in diabetes mellitus and is associated with retinopathy. Rev Diabet Stud 2011; 8: 268-275
- 17 George NS, Rangan V, Geng Z. et al. Distribution of esophageal motor disorders in diabetic patients with dysphagia. J Clin Gastroenterol 2017; 51: 890-895
- 18 Wang X, Pitchumoni CS, Chandrarana K. et al. Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy. World J Gastroenterol 2008; 14: 709-712
- 19 Ayazi S, Hagen JA, Chan LS. et al. Obesity and gastroesophagealreflux: Quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter statusin a large series of patients with reflux symptoms. J Gastrointest Surg 2009; 13: 1440-144
- 20 Hajar N, Castell DO, Ghomrawi H. et al. Impedance pH confirms the relationship between GERD and BMI. Dig Dis Sci 2012; 57: 1875-1879
- 21 Schneider JM, Brücher BL, Küper M. et al. Multichannel intraluminal impedance measurement of gastroesophageal reflux in patients with different stages of morbid obesity. Obes Surg 2009; 19: 1522-1529